Cargando…
Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis
BACKGROUND: Liver cirrhosis is the end stage of various chronic liver diseases (CLDs). The gut microbiota can impact the liver environment and trigger chronic liver inflammation through the gut-liver axis. Alteration of the gut microbiota has become an effective strategy in the biological treatment...
Autores principales: | Wu, Zengrong, Zhou, Hejun, Liu, Deliang, Deng, Feihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361729/ https://www.ncbi.nlm.nih.gov/pubmed/37483387 http://dx.doi.org/10.3389/fcimb.2023.1218552 |
Ejemplares similares
-
Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome
por: Yu, Xiao, et al.
Publicado: (2022) -
Probiotic Supplementation During Human Pregnancy Affects the Gut Microbiota and Immune Status
por: Chen, Yuyi, et al.
Publicado: (2019) -
The Effects of Chinese Medicine QRD, Antibiotics, and Probiotics on Therapy and Gut Microbiota in Septic Rats
por: Cao, Huiling, et al.
Publicado: (2021) -
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
por: Anjana,, et al.
Publicado: (2022) -
Analysis of the gut microbiota in children with gastroesophageal reflux disease using metagenomics and metabolomics
por: Ye, Xiaolin, et al.
Publicado: (2023)